期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性肾损伤早期诊断生物标志物研究进展 被引量：2

Early Biomarkers for the Diagnosis of Acute Kidney Injury
原文传递
导出
摘要 急性肾损伤(Acute kidney injury,AKI)可发生于各临床科室其临床经过常见并严重,ICU的重症患者AKI的发病率和死亡率更高。早期诊断对AKI的预后影响重大,能否找到临床实用的早期预测AKI的生物学标志物尽早采取干预措施是改善其预后的关键。本文就近年来研究的几种具有潜力的生物标志物作一综述。 Acute kidney injury（AKI） is a common and serious procedure that occurs in a wide variety of clinical division.AKI has higher morbidity and mortality in intensive care unit.Its early diagnosis and intervention has a world of effect on its prognosis.Thus it is a key point that we can find out biomarkers to predict AKI and adopt therapeutic measure as early as possible to ameliorate its prognosis.The study of some potential biological markers in recent yeas is reviewed in this article.
作者 陈姚 李新宇
机构地区 石河子大学医学院 兰州军区乌鲁木齐总医院ICU
出处 《现代生物医学进展》 CAS 2012年第4期760-761,738,共3页 Progress in Modern Biomedicine
基金 兰州军区科研基金项目(XLH2009027)
关键词 急性肾损伤 早期诊断 生物标志物 Acute kidney injury Early diagnosis Biomarker
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献17

  • 1Barbara Lisowska-Myjak.Serum and urinary biomarkers of acutekidney injury[J].Blood Purif 2010,29(4):357-365.
  • 2Mishra J,Ma Q,Prada A,et al.Identification of neutrophil gelatinaseassociated lipocalin as a novel early urinary biomarker for ischemicrenal injury[J].J Am Soc Nephrol,2003,14(10):2534-2543.
  • 3Kjeldsen L,Cowland JB,Borregaard N.Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse[J].Biochim Biophys Acta,2000,1482(1-2):272-283.
  • 4Dinna N.Cruz,Massimo de Cal,et al.Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in anadult ICU population[J].Intensive Care Med,2010,36(3):444-451.
  • 5钟白云,王堃,廖经忠,石海鹏.血清胱抑素-C与危重病人急性肾损伤[J].中国现代医学杂志,2009,19(11):1705-1709. 被引量：19
  • 6齐法莲,徐军,杜秀敏.白细胞介素-18与临床疾病关系的研究(文献综述)[J].放射免疫学杂志,2005,18(5):378-380. 被引量：6
  • 7E.Moore,R.Bellomo.Biomarkers of acute kidney injury in anesth-esia,intensive care and major surgery:from the benth to clinicalresearch to clinical practice[J].Minerva Anestesiol,2010,76(6):425-440.
  • 8Melnikov VY,Ecder T,Fantuzzi G,et al.Impaired IL-18 processingprotects caspase-1-deficient mice from ischemic acute renal failure[J].Clin Invest,2001,107(9):1455-1152.
  • 9Parikh CR,JaniA,Mishra J,et al.Urinary interleukin-18 is a marker ofhuman acute tutbular necrosis[J].Am J Kidney Dis,2004,43(3):405-414.
  • 10Parikh CR,JaniA,Mishra J,et al.Urine NGAL and IL-18 are predic-tive biomarkers for delayed graft function following kidney transplan-tation[J].Am J Transplant,2006,6(7):1639-1645.

二级参考文献27

共引文献22

同被引文献26

  • 1Kanagasundaram S. The NICE acute kidney injury guideline: questions still unanswered [J]. Br J Hosp Med (Lond), 2013, 74(12): 664-665.
  • 2Canet E, Cheminant M, Zafrani L, et al. Plasma Uric Acid Response to Rasburicase: Early Marker for Acute Kidney Injury in Turnout Lysis Syndrome[J]. Leuk Lymphoma, 2013.
  • 3Zonies D, DuBose J, Elterman J, et al. Early implementation of continuous renal replacement therapy optimizes casualty evacuation for combat-related acute kidney injury [J]. J Trauma cute Care Surg, 2013, 75(2): 210-204.
  • 4Gaillot T, Ozanne B, B6 tr6 mieux P, et al. Acute renal replacement therapy in pediatrics[J]. Ann Fr Anesth Reanim,2013,32(12): 231-236.
  • 5Wald R, Shariff SZ, Adhikari NK, et al. The Association Between enal Replacement Therapy Modality and Long-Term Outcomes Among Critically III Adults With Acute Kidney Injury: A Retrospective Cohort Study[J]. Crit Care Med, 2013.
  • 6Tovey L, Dickie H, Gangi S, et al. Beyond the randomized clinical trial: citrate for continuous renal replacement therapy in clinical practice[J]. Nephron Clin Pratt, 2013, 124(1-2): 119-123.
  • 7de Geus HR, Fortrie G, Betjes MG, et al. Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patients[J]. BMC Nephrol, 2013, 14(1): 273.
  • 8Symons JM, McMahon MW, Karamlou T, et al. Continuous renal replacement therapy with an automated monitor is superior to a free-flow system during extracorporeal life support [J]. Pediatr Crit Care Med, 2013, 14(9): 404-408.
  • 9Jiang SP, Zhu ZY, Ma KF, et al. Impact of pharmacist antimierobial dosing adjustments in septic patients on continuous renal replacement therapy in an intensive care unit [J]. Seand J Infect Dis, 2013, 45(12):891-899.
  • 10Johansson M, Nozohoor S, Bjursten H, et al. Acute Kidney Injury Assessed by Cystatin C after Transcatheter Aortic Valve Implantation and Late Renal Dysfunction[J]. J Cardiothorac Vasc Anesth, 2013.

引证文献2

二级引证文献20

现代生物医学进展
2012年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部